Today I am speaking to Mukhtar Ahmed, who has a career spanning across major CRO’s and significant eclinical businesses for over 25 years. He is currently President of the Science Group at Clarivate, specialising in high growth subscription analytics, data sciences and consulting services to the healthcare, biopharma, medical device, academic research, publishing and corporate R&D sectors. In this podcast, Mukhtar discusses his view on the possible implications of Covid-19 on the wider healthcare space.

Listen to the Podcast below: